Literature DB >> 11178868

Cocaine-induced expression of the tetraspanin CD81 and its relation to hypothalamic function.

M S Brenz Verca1, D A Widmer, G C Wagner, J Dreyer.   

Abstract

CD81, a tetraspanin transmembrane protein involved in cell adhesion, was found by differential display to be upregulated in the nucleus accumbens of rat brain following acute cocaine treatment (four injections of 30 mg/kg every 2 h followed by 24 h withdrawal). Cocaine-induced expression of CD81 in adult rat brain was confirmed by quantitative real-time RT-PCR. Its expression in neurons and its function in the brain are unknown. In situ hybridization shows a neuron-specific expression pattern in brain regions functionally related to the regulation of cardiovascular function and fluid homeostasis. CD81 displays codistribution to galanin and, to a lesser extent, to vasopressin. These findings add to data that suggest a connection between the brain reward pathway and the centers regulating endocrine and autonomic functions, in relation to neurochemical, behavioral, and somatic consequences of drug abuse. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11178868     DOI: 10.1006/mcne.2000.0942

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  15 in total

1.  Chromatin immunoprecipitation assays revealed CREB and serine 133 phospho-CREB binding to the CART gene proximal promoter.

Authors:  George A Rogge; Li-Ling Shen; Michael J Kuhar
Journal:  Brain Res       Date:  2010-05-06       Impact factor: 3.252

Review 2.  Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions.

Authors:  Jean-Luc Dreyer
Journal:  Mol Biotechnol       Date:  2011-02       Impact factor: 2.695

Review 3.  Regulatable gene expression systems for gene therapy applications: progress and future challenges.

Authors:  S Goverdhana; M Puntel; W Xiong; J M Zirger; C Barcia; J F Curtin; E B Soffer; S Mondkar; G D King; J Hu; S A Sciascia; M Candolfi; D S Greengold; P R Lowenstein; M G Castro
Journal:  Mol Ther       Date:  2005-08       Impact factor: 11.454

Review 4.  Regulatable gene expression systems for gene therapy.

Authors:  Nuria Vilaboa; Richard Voellmy
Journal:  Curr Gene Ther       Date:  2006-08       Impact factor: 4.391

5.  Role of matrix metalloproteinases in the acquisition and reconsolidation of cocaine-induced conditioned place preference.

Authors:  Travis E Brown; Melissa R Forquer; Davelle L Cocking; Heiko T Jansen; Joseph W Harding; Barbara A Sorg
Journal:  Learn Mem       Date:  2007-03-09       Impact factor: 2.460

Review 6.  CART peptides: regulators of body weight, reward and other functions.

Authors:  G Rogge; D Jones; G W Hubert; Y Lin; M J Kuhar
Journal:  Nat Rev Neurosci       Date:  2008-10       Impact factor: 34.870

Review 7.  Cocaine- and amphetamine-regulated transcript peptides play a role in drug abuse and are potential therapeutic targets.

Authors:  Michael J Kuhar; Jason N Jaworski; George W Hubert; Kelly B Philpot; Geraldina Dominguez
Journal:  AAPS J       Date:  2005-09-02       Impact factor: 4.009

8.  Intra-VTA CART 55-102 reduces the locomotor effect of systemic cocaine in rats: an isobolographic analysis.

Authors:  Jason N Jaworski; Heather L Kimmel; Darlene A Mitrano; Ronald J Tallarida; Michael J Kuhar
Journal:  Neuropeptides       Date:  2007-02-07       Impact factor: 3.286

9.  Genetic variants in the cocaine- and amphetamine-regulated transcript gene (CARTPT) and cocaine dependence.

Authors:  Falk W Lohoff; Paul J Bloch; Andrew E Weller; Aleksandra H Nall; Glenn A Doyle; Russell J Buono; Thomas N Ferraro; Kyle M Kampman; Helen M Pettinati; Charles A Dackis; David W Oslin; Charles P O'Brien; Wade H Berrettini
Journal:  Neurosci Lett       Date:  2008-05-24       Impact factor: 3.046

10.  Persistent alterations in mesolimbic gene expression with abstinence from cocaine self-administration.

Authors:  Willard M Freeman; Kruti M Patel; Robert M Brucklacher; Malinda E Lull; Mandi Erwin; Drake Morgan; David C S Roberts; Kent E Vrana
Journal:  Neuropsychopharmacology       Date:  2007-09-12       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.